Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Influence of p53 and bcl-2 on proliferative activity and treatment outcome in head and neck cancer patients.

Oral oncology - 1 Jan 2000

Dijkema I M, Struikmans H, Dullens H F, Kal H B, van der Tweel I, Battermann J J

Abstract excerpt

Knowledge about the influence of biomarkers on cell proliferative activity might explain differences in radiosensitivity between head and neck tumors and might improve patient selection for the most optimal treatment strategy. p53 and bcl-2 protein expression were determined immunohistochemically in 56 head and neck cancer patients, treated by surgery only in five cases and by radiotherapy, with or without...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Squamous Cell
Share to Cell Division

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Head and Neck Neoplasms

Share to Immunohistochemistry

Share to Prognosis

Share to Proto-Oncogene Proteins c-bcl-2

Share to Treatment Outcome

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 10889920
DOI: 10.1016/s1368-8375(99)00051-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Influence of p53 and bcl-2 on proliferative activity and treatment outcome in head and neck cancer patients.PMID 10889920Read ↗

Potential indicators of radiosensitivity in squamous cell carcinoma of the head and neckSemantic proximity Read ↗

The bcl-2 gene status of human head and neck cancer cell lines.Semantic proximity Read ↗

Mutation of p53 in squamous cell cancer of the head and neck: relationship to tumor cell proliferation.Semantic proximity Read ↗

Cumulative prognostic value of p53 mutations and bcl-2 protein expression in head-and-neck cancer treated by radiotherapy.Semantic proximity Read ↗

The effect of irradiation on mitotic and apoptotic frequency in head and neck cancer cell lines, the correlation to p53 mutations and clonogenic survival.Semantic proximity Read ↗

Overexpression of Bcl‐2 in squamous cell carcinoma of the larynx: A marker of radioresistanceSemantic proximity Read ↗

Ki-67 and p53 in T2 laryngeal cancer.Semantic proximity Read ↗

Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck.Semantic proximity Read ↗

p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines.Semantic proximity Read ↗

Interaction between potential doubling time and TP53 mutation: predicting radiotherapy outcome in squamous cell carcinoma of the head and neck.Semantic proximity Read ↗

Protein expression of p53 and Bcl-2 has a strong correlation with radiation resistance of laryngeal squamous cell carcinoma but does not predict the radiation failure before treatment.Semantic proximity Read ↗

Gene status of head and neck squamous cell carcinoma cell lines and cetuximab-mediated biological activities.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.